ChromaCode Adds Industry Leaders, Pat Balthrop and Kevin O’Boyle, to Board of Directors

CARLSBAD, Calif.–(BUSINESS WIRE)– #analysis–ChromaCode, Inc., a company that combines data science and proprietary reagents to improve clinical molecular analysis, today announced that Patrick Balthrop, Sr. and Kevin O’Boyle have joined the company’s Board of Directors. Mr. Balthrop is the former CEO and President of Luminex, a pioneer in multiplexed diagnostics platform development; chairman of the Board at Agendia, Inc, a molecular diagnostic company focused on oncology diagnostics for breast cancer;
Click here to view original post